---
$id: https://graph.org.ai/products/commodity/51263165
$type: Product
source: UNSPSC
code: "51263165"
title: "Levobunolol hydrochloride"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levobunolol hydrochloride

**UNSPSC Code**: 51263165
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C17H25NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O90S49LDHH, chemically known as 1(2h)-naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)- but more generally known as levobunolol hydrochloride, which bears US NIH Compound Identifier 34060. European Medicines Agency schedules Levobunolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14351MIG. Most nations, for tariff and trade purposes, schedule levobunolol hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, LEVOBUNOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Levobunolol hydrochloride bears US NLM identifiers UMLS ID C0591174 and NCI Concept Code C29153. SMILES: CC(C)(C)NC[C@@H](COC1CCCC2C1CCCC2=O)O.CL.

